靶向急性髓系白血病中的表观遗传-免疫轴：当前进展与未来方向

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

靶向白血病干细胞的脂质体纳米免疫疗法通过沉默 B 细胞淋巴瘤 2 逆转免疫逃逸并抑制融合癌蛋白驱动的急性髓系白血病

Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silen

异基因移植后急性髓系白血病复发中重编程失败的移植物抗白血病免疫的研究进展

Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.

急性髓系白血病双特异性抗体：从骨髓免疫龛到临床转化

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

探索 CAR-T 之外的 CAR 细胞疗法用于髓系恶性肿瘤

Exploring CAR cell therapies beyond CAR-T for myeloid malignancies.

CAR-T 与 CAR NK 细胞治疗急性髓系白血病的最新进展

Recent advances in CAR T and CAR NK cell therapy for AML.

CAR-T 治疗急性髓系白血病的临床前进展与机制见解：从靶点迭代到微环境调控

Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation.

本综述系统总结了 CAR-T 疗法治疗 AML 的临床前进展及机制基础，聚焦于两大核心瓶颈。

AML 中的 CAR-T 与 CAR-NK 细胞疗法：打破壁垒，规划未来

CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future.

母细胞性浆细胞样树突状细胞肿瘤：病例报告

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.

单链可变区片段亲和力调谐可优化抗 AML CAR-NK 细胞功能

Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality.

在 NK 细胞中表达具有不同 CD123 结合亲和力的 26292 和 7G3 CAR 可导致针对 AML 的抗原特异性激活和细胞毒性。基于亲和力的功能激活和抗肿瘤活性差异取决于时间进程，并且具有 scFv/表位特异性。